Dr Kuo, MD, MBA, has over 20 years of experience in the life science industry as a venture capitalist, pharmaceutical business development executive and senior manager of private and publicly-traded biotech companies. Previously, Dr. Kuo served as Chairman and Chief Executive Officer of Adeona Pharmaceuticals.

Dr. Motwani has over 25 years of experience in research and business development and technology licensing in biotechnology. She has been successful in recruiting the current technical and management team and scientific advisors. Under her leadership, the predecessor company, ApoLife, has been successful in receiving NIH grant awards, developing technology and negotiating licensing deals which generate current revenues. She focuses on technolog

Formerly VP of Business development at Crucell NV and VP Business Development at BioWA, two antibody platform companies. She has successfully negotiated licensing deals of over $3.6B for biopharma companies with antibody platforms and is securing new licensing partners for BioSavita.

David has 20 years of experience in R&D, business development and licensing in biotech. He was Dir of Licensing at RCT from 2007-11 where he managed out-licensing platform technologies, including 50 licensees of Pichia yeast expression technology. Prior to this, David was associate director at Merck Research Labs for 14 years where he led evaluation of all technology platforms required for discovery and development of therapeutic mAbs.